Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Poyner

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Expert Opinion on Drug Discovery|March 14, 2013
CGRP receptor antagonists: design and screeningDavid R Poyner, Debbie L Hay, Alex C Conner
Pharmacology & Therapeutics|August 23, 2005
GPCR modulation by RAMPsDebbie L Hay, David R Poyner, Patrick M Sexton
Methods in Molecular Biology (Clifton, N.J.)|May 25, 2011
The use of site-directed mutagenesis to study GPCRsAlex C Conner, James Barwell, David R Poyner, et al.
Biophysical Journal|April 25, 2006
Characterization of the structure of RAMP1 by mutagenesis and molecular modelingJohn Simms, Debbie L Hay, Mark Wheatley, et al.
British Journal of Pharmacology|June 11, 2011
The pharmacology of adrenomedullin 2/intermedinYanguo Hong, Debbie L Hay, Remi Quirion, et al.
Peptides|November 17, 2009
Mapping interaction sites within the N-terminus of the calcitonin gene-related peptide receptor; the role of residues 23-60 of the calcitonin receptor-like receptorJames Barwell, Philip S Miller, Dan Donnelly, et al.
British Journal of Pharmacology|October 24, 2017
Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25Debbie L Hay, Michael L Garelja, David R Poyner, et al.
Advances in Experimental Medicine and Biology|March 22, 2012
RAMPs and CGRP receptorsJames Barwell, Denise Wootten, John Simms, et al.
Trends in Pharmacological Sciences|July 17, 2010
Regulation of signal transduction by calcitonin gene-related peptide receptorsChristopher S Walker, Alex C Conner, David R Poyner, et al.
Drug Discovery Today|January 20, 2009
Modulating receptor function through RAMPs: can they represent drug targets in themselves?Patrick M Sexton, David R Poyner, John Simms, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Expert Opinion on Drug Discovery|March 14, 2013
CGRP receptor antagonists: design and screeningDavid R Poyner, Debbie L Hay, Alex C Conner
Pharmacology & Therapeutics|August 23, 2005
GPCR modulation by RAMPsDebbie L Hay, David R Poyner, Patrick M Sexton
Methods in Molecular Biology (Clifton, N.J.)|May 25, 2011
The use of site-directed mutagenesis to study GPCRsAlex C Conner, James Barwell, David R Poyner, et al.
Biophysical Journal|April 25, 2006
Characterization of the structure of RAMP1 by mutagenesis and molecular modelingJohn Simms, Debbie L Hay, Mark Wheatley, et al.
British Journal of Pharmacology|June 11, 2011
The pharmacology of adrenomedullin 2/intermedinYanguo Hong, Debbie L Hay, Remi Quirion, et al.
Peptides|November 17, 2009
Mapping interaction sites within the N-terminus of the calcitonin gene-related peptide receptor; the role of residues 23-60 of the calcitonin receptor-like receptorJames Barwell, Philip S Miller, Dan Donnelly, et al.
British Journal of Pharmacology|October 24, 2017
Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25Debbie L Hay, Michael L Garelja, David R Poyner, et al.
Advances in Experimental Medicine and Biology|March 22, 2012
RAMPs and CGRP receptorsJames Barwell, Denise Wootten, John Simms, et al.
Trends in Pharmacological Sciences|July 17, 2010
Regulation of signal transduction by calcitonin gene-related peptide receptorsChristopher S Walker, Alex C Conner, David R Poyner, et al.
Drug Discovery Today|January 20, 2009
Modulating receptor function through RAMPs: can they represent drug targets in themselves?Patrick M Sexton, David R Poyner, John Simms, et al.
Pageof 8